Alexion to Buy Portola in $1.4 Billion Effort to Diversify

(Bloomberg) -- Alexion Pharmaceuticals Inc. agreed to buy Portola Pharmaceuticals Inc. for about $1.4 billion, in a deal the drugmaker expects will help it diversify after an activist investor push...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.